EU OK's Schering's Remicade for colitis

Published: March. 9, 2006 at 10:55 AM

KENILWORTH, N.J., March 9 (UPI) -- Schering-Plough said Thursday the European Commission approved Remicade for the treatment of ulcerative colitis.

The indication, which is for moderately to severely active ulcerative colitis in patients who have failed on conventional therapies, was supported by the ACT 1 and ACT 2 phase 3 trials.

"Our research demonstrated that UC patients treated with Remicade achieved mucosal healing and disease remission while they had failed conventional therapies," Paul Rutgeerts of the University Hospital Gasthuisberg in Leuven, Belgium, and lead investigator of the ACT 2 trial, said in a statement issued by Schering.

"These patients with UC had limited treatment options, with many facing surgery," Rutgeerts said. "Remicade represents a significant advance for these patients."

Remicade is approved in the European Union for several other inflammatory diseases, including Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.

© 2006 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Man claiming to be a killer arrested (6 min)
Horse poop excluded from scooping law (8 min)
Bra unrolls into putting mat (22 min)
Intellectually disabled need health ed (23 min)
NASA readies WISE for December launch (24 min)
'Too realistic' riot exercise called off (40 min)
Mucosal immune mechanism identified (43 min)
fark
The coolest photo of Devils Tower you've seen since your routine training flight went missing in...
Find yourself recently single and with no clue how to proceed? You are in luck. Come on out to the...
Remember when New London took those homes and the Supreme Court said it was OK because they had...
The deep-sea crab that eats trees....who knew you can grow trees at the bottom of the ocean
Photoshop these masks
New Jersey judge allows quadriplegic man to buy guns. "He plans to mount the gun on his wheelchair...